BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7731684)

  • 1. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer.
    Woodruff KA; Rosenblatt JD; Moore TB; Medzoyan RH; Pai DS; Noland JL; Yamashiro JM; Wada RK
    Oncogene; 1995 Apr; 10(7):1335-41. PubMed ID: 7731684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
    Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
    Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W; Schwab M
    Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of estrogen activation of c-myc oncogene expression.
    Dubik D; Shiu RP
    Oncogene; 1992 Aug; 7(8):1587-94. PubMed ID: 1630819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late promoter selection in the baculovirus gp64 envelope fusion protein gene.
    Garrity DB; Chang MJ; Blissard GW
    Virology; 1997 May; 231(2):167-81. PubMed ID: 9168879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
    Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region.
    Ge YW; Ghosh C; Song W; Maloney B; Lahiri DK
    J Neurochem; 2004 Sep; 90(6):1432-44. PubMed ID: 15341527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of gene expression in mammary epithelial cells by cellular confluence and sequence-specific DNA binding factors.
    Altiok S; Groner B
    Biochem Soc Symp; 1998; 63():115-31. PubMed ID: 9513716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CD34 expression in differentiating M1 cells.
    Krause DS; Kapadia SU; Raj NB; May WS
    Exp Hematol; 1997 Sep; 25(10):1051-61. PubMed ID: 9293902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of two nuclear factors to a novel silencer element in human dentin matrix protein 1 (DMP1) promoter regulates the cell type-specific DMP1 gene expression.
    Chen S; Inozentseva-Clayton N; Dong J; Gu TT; MacDougall M
    J Cell Biochem; 2004 May; 92(2):332-49. PubMed ID: 15108359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
    Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.